Literature DB >> 8888686

Cardiac efficiency is improved after ischemia by altering both the source and fate of protons.

B Liu1, A S Clanachan, R Schulz, G D Lopaschuk.   

Abstract

Cardiac efficiency is decreased in hearts after severe ischemia. We determined whether reducing the production of H+ from glucose metabolism or inhibiting the clearance of H+ via Na(+)-H+ exchange could increase cardiac efficiency during reperfusion. This was achieved using dichloroacetate (DCA) to stimulate glucose oxidation and 5-(N,N-dimethyl)-amiloride (DMA) to inhibit Na(+)-H+ exchange, respectively. Isolated working rat hearts were subjected to 30 minutes of global ischemia and 60 minutes of reperfusion. Glycolysis and oxidation rates of glucose, lactate, and palmitate were measured. Recovery of cardiac work, O2 consumption (MVO2), and rates of acetyl-coenzyme A and ATP production during reperfusion were determined. After ischemia, cardiac work recovered to 35 +/- 5% of preischemic values in control hearts (n = 23), although MVO2, tricarboxylic acid (TCA) cycle activity, and ATP production from glycolysis and oxidative metabolism rapidly recovered to preischemic levels. This decrease in cardiac efficiency was accompanied by a substantial production of H+ from glucose metabolism DCA caused a 2.2-fold increase in glucose oxidation, a 46 +/- 17% decrease in H+ production, a 1.6-fold increase in cardiac efficiency, and a 2.0-fold increase in cardiac work during reperfusion (n = 17). Inhibition of Na(+)-H+ exchange with DMA did not alter TCA cycle activity and ATP production rates but did result in a 1.8-fold increase in cardiac efficiency and a 1.7-fold increase in cardiac work (n = 12). These data show that cardiac efficiency and the contractile function after ischemia can be improved by either reducing the rate of H+ production from glucose metabolism during reperfusion or inhibiting the clearance of H+ via Na(+)-H+ exchange. Our data suggest that an increased requirement for ATP to restore ischemia-reperfusion-induced alterations in ion homeostasis contributes to the decrease in cardiac efficiency and contractile function after ischemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888686     DOI: 10.1161/01.res.79.5.940

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  50 in total

Review 1.  Age-related cardiovascular disease and the beneficial effects of calorie restriction.

Authors:  Miranda M Y Sung; Jason R B Dyck
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 2.  Targeting myocardial substrate metabolism in heart failure: potential for new therapies.

Authors:  Hossein Ardehali; Hani N Sabbah; Michael A Burke; Satyam Sarma; Peter P Liu; John G F Cleland; Aldo Maggioni; Gregg C Fonarow; E Dale Abel; Umberto Campia; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2012-02       Impact factor: 15.534

3.  Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt/mTORC2 signaling.

Authors:  Janet R Manning; Dharendra Thapa; Manling Zhang; Michael W Stoner; Javier Traba; Catherine Corey; Sruti Shiva; Michael N Sack; Iain Scott
Journal:  Biochem J       Date:  2019-06-19       Impact factor: 3.857

Review 4.  Hexokinases and cardioprotection.

Authors:  Guillaume Calmettes; Bernard Ribalet; Scott John; Paavo Korge; Peipei Ping; James N Weiss
Journal:  J Mol Cell Cardiol       Date:  2014-09-26       Impact factor: 5.000

Review 5.  Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series).

Authors:  Sowndramalingam Sankaralingam; Gary D Lopaschuk
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

Review 6.  Nutrient sensing and utilization: Getting to the heart of metabolic flexibility.

Authors:  Timothy M Griffin; Kenneth M Humphries; Michael Kinter; Hui-Ying Lim; Luke I Szweda
Journal:  Biochimie       Date:  2015-10-22       Impact factor: 4.079

7.  Influence of dark phase restricted high fat feeding on myocardial adaptation in mice.

Authors:  Ju-Yun Tsai; Carolina Villegas-Montoya; Brandon B Boland; Zachary Blasier; Oluwaseun Egbejimi; Raquel Gonzalez; Michael Kueht; Tracy A McElfresh; Rachel A Brewer; Margaret P Chandler; Molly S Bray; Martin E Young
Journal:  J Mol Cell Cardiol       Date:  2012-09-29       Impact factor: 5.000

8.  Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model.

Authors:  Angelical S Martin; Dennis M Abraham; Kathleen A Hershberger; Dhaval P Bhatt; Lan Mao; Huaxia Cui; Juan Liu; Xiaojing Liu; Michael J Muehlbauer; Paul A Grimsrud; Jason W Locasale; R Mark Payne; Matthew D Hirschey
Journal:  JCI Insight       Date:  2017-07-20

9.  Impact of anaerobic glycolysis and oxidative substrate selection on contractile function and mechanical efficiency during moderate severity ischemia.

Authors:  Lufang Zhou; Hazel Huang; Tracy A McElfresh; Domenick A Prosdocimo; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

10.  The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.

Authors:  Lin Piao; Yong-Hu Fang; Virgilio J J Cadete; Christian Wietholt; Dalia Urboniene; Peter T Toth; Glenn Marsboom; Hannah J Zhang; Idith Haber; Jalees Rehman; Gary D Lopaschuk; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2009-12-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.